(2017). Acquired resistance to erlotinib in EGFR mutation-positive lung adenocarcinoma among Hispanics (CLICaP).
Chicago Style (17th ed.) CitationAcquired Resistance to Erlotinib in EGFR Mutation-positive Lung Adenocarcinoma Among Hispanics (CLICaP). 2017.
MLA (8th ed.) CitationAcquired Resistance to Erlotinib in EGFR Mutation-positive Lung Adenocarcinoma Among Hispanics (CLICaP). 2017.
Warning: These citations may not always be 100% accurate.
